Stay updated on MK-2640 Safety and Efficacy in Diabetes Clinical Trial
Sign up to get notified when there's something new on the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page.

Latest updates to the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedSite revision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check18 days agoChange DetectedDifference0.0%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedRevision: v3.4.2 is a site version update and the temporary funding-status notice was removed. No substantive changes were made to the study data, eligibility criteria, or outcomes.SummaryDifference0.4%

- Check54 days agoChange DetectedAn administrative notice about lapse in government funding was added and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedShow glossary option is now visible to help users understand technical terms. Meta labels were updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision version updated to v3.4.0.SummaryDifference0.2%

- Check75 days agoChange DetectedPage footer shows a revision update: v3.3.3 was replaced by v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to MK-2640 Safety and Efficacy in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-2640 Safety and Efficacy in Diabetes Clinical Trial page.